Meningococcal

Section Editor(s): Ronald Ellis, Biotech and Biopharma, Jerusalem, IL

Meningococcal vaccine, polysaccharide and conjugate, research, development, preclinical, clinical, safety, epidemiology, cost, and economics.

Back to Sections

Modify your search

Advanced

Human Vaccines & Immunotherapeutics sections

  • Showing 1-10 of 18 results for search:

Filters
Modify your search
Download citations Download PDFs
  4. Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)Open Access
    Adriana Efron, Alessia Biolchi, Cecilia Sorhouet Pereira, Sara Tomei, Josefina Campos, Denise De Belder, María Alicia Moscoloni, Mauricio Santos, Gabriela Vidal, Florencia Nocita, Carla Vizzotti & Mariagrazia Pizza
    Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 3
    Brief Report | Published online: 18 Dec 2023 | Views: 557
    Full Text
  8. Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian childrenOpen Access
    Samba O. Sow, Milagritos D. Tapia, Fadima Cheick Haidara, Fatoumata Diallo, Youssouf Traore, Awa Traoré, Mamoudou Kodio, Ray Borrow, Kelly Townsend-Payne, Lin Yuan, Shuyuan Yang, Lei Shi, Jingjing Chen, Guoliang Fang, Jianxiang Lin, Ruoyu Hu, Simonetta Viviani & Zhen Huang
    Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 2
    Article | Published online: 04 Jul 2023 | Views: 1456
    Full Text